Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0001654151-24-000007
Filing Date
2024-04-11
Accepted
2024-04-11 07:10:47
Documents
20
Period of Report
2024-06-20

Document Format Files

Seq Description Document Type Size
1 PRE 14A dcph-20240411.htm   iXBRL PRE 14A 1259677
6 dcph-20240411_g1.jpg GRAPHIC 168859
7 dcph-20240411_g2.jpg GRAPHIC 17394
8 dcph-20240411_g3.jpg GRAPHIC 160882
9 dcph-20240411_g4.jpg GRAPHIC 131809
10 dcph-20240411_g5.jpg GRAPHIC 104018
  Complete submission text file 0001654151-24-000007.txt   3521509

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dcph-20240411.xsd EX-101.SCH 3399
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dcph-20240411_def.xml EX-101.DEF 4377
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dcph-20240411_lab.xml EX-101.LAB 5860
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dcph-20240411_pre.xml EX-101.PRE 3382
23 EXTRACTED XBRL INSTANCE DOCUMENT dcph-20240411_htm.xml XML 180627
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

EIN.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-38219 | Film No.: 24837119
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)